-transparent.png){kind=logo}
Protein kinase C (PKC) regulates many cellular processes. In view of its possible relevance to the drug resistance, the levels of PKC activity were assessed in human leukemia cell lines with reference to the sensitivity to antineoplastic agents. K562/ADM exhibited approximately 2-fold higher levels of PKC activity as compared with the parental K562. After a 1-hr preincubation with Adriamycin (ADM) (0.5, 1, 10 microM), PKC activity in K562 tended to increase dose-dependently, while no substantial alteration was found in K562/ADM. Cisplatin (CDDP) or etoposide was of no effect. The activity in THP-1/E was slightly lower than THP-1, and the basal level stayed unchanged with any one of the above drugs. These results suggest that in K562 increase in PKC activity with ADM may play a role in the process of acquisition of resistance.
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
April 1989,
FEBS letters,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
January 1992,
Hematological oncology,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
March 1996,
International journal of oncology,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
February 2002,
Free radical biology & medicine,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
March 1991,
Laryngo- rhino- otologie,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
January 1998,
Izvestiia Akademii nauk. Seriia biologicheskaia,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
October 1987,
Biochemical and biophysical research communications,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
June 1997,
The Journal of biological chemistry,
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
January 1990,
European journal of cancer (Oxford, England : 1990),
S Sugawara, and
N Kumano, and
Y Saijo, and
S Suzuki, and
Y Numata, and
G Sato, and
M Motomiya
May 1994,
FEBS letters,
